Condition: Bradycardia · Atrio-Ventricular Block · Syncope · Sponsor: Royal Brompton & Harefield NHS Foundation Trust
This observational study will follow patients requiring implantation of leadless pacemaker for 5 years after implantation. The main goal is to evaluate the long term safety and efficacy of AVEIR™ leadless pacemaker device in the usual clinical settings within the UK National Health Service. In addition, the study will collect data to understand patient characteristics receiving this type of pacemaker.
This description comes directly from the study's public registry record.
Ines Kralj-Hans, PhD · 0330128 8854 · i.kralj-hans@rbht.nhs.uk
Veronica Tudor · 0330128 8854 · v.tudor@rbht.nhs.uk
Always discuss trial participation with your own doctor first.
| Royal Brompton Hospital | London, UK, United Kingdom | Recruiting |
| The Royal Brompton Hospital | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06854484